Jenburkt [JENBURPH] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison

Jenburkt

BSE
Loading...

Sequent Scientific

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Jenburkt wins in 15 metrics, Sequent Scientific wins in 4 metrics, with 0 ties. Jenburkt appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricJenburktSequent ScientificBetter
P/E Ratio (TTM)14.89166.33Jenburkt
Price-to-Book Ratio2.816.61Jenburkt
Debt-to-Equity Ratio2.2762.47Jenburkt
PEG Ratio2.911.40Sequent Scientific
EV/EBITDA11.8830.63Jenburkt
Profit Margin (TTM)20.97%1.85%Jenburkt
Operating Margin (TTM)23.18%7.56%Jenburkt
EBITDA Margin (TTM)23.18%7.56%Jenburkt
Return on Equity18.66%2.84%Jenburkt
Return on Assets (TTM)16.34%1.37%Jenburkt
Free Cash Flow (TTM)$81.92M$442.73MSequent Scientific
Dividend Yield2.48%N/AN/A
1-Year Return8.77%-10.14%Jenburkt
Price-to-Sales Ratio (TTM)3.123.00Sequent Scientific
Enterprise Value$4.67B$50.87BSequent Scientific
EV/Revenue Ratio3.023.17Jenburkt
Gross Profit Margin (TTM)81.65%46.86%Jenburkt
Revenue per Share (TTM)$351$64Jenburkt
Earnings per Share (Diluted)$73.46$1.12Jenburkt
Beta (Stock Volatility)0.380.91Jenburkt
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Jenburkt vs Sequent Scientific Stock Performance Analysis

Loading Price Chart...

Jenburkt
Sequent Scientific
Jenburkt Stock Overview | Sequent Scientific Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Jenburkt-0.42%-1.85%-5.15%-20.20%5.78%-11.50%
Sequent Scientific1.15%-8.42%9.29%-3.35%37.17%0.89%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Jenburkt8.77%96.74%188.92%120.06%1,195.02%2,298.67%
Sequent Scientific-10.14%69.59%19.72%26.36%26.36%26.36%

News Based Sentiment: Jenburkt vs Sequent Scientific

Jenburkt

News based Sentiment: MIXED

September presented a mixed bag for Jenburkt Pharmaceuticals, with positive year-over-year growth in revenue and profit countered by short-term declines and a negative market sentiment. The closure of the trading window signals an upcoming earnings release that will be pivotal in shaping the company's investment narrative.

View Jenburkt News Sentiment Analysis

Sequent Scientific

News based Sentiment: POSITIVE

Sequent Scientific's impressive Q1 FY2025-26 results, with a 21.9% revenue increase and a massive 1283.5% profit jump, clearly demonstrate a positive shift in the company's financial performance. This strong showing is a significant development for investors, indicating potential for future growth and returns.

View Sequent Scientific News Sentiment Analysis

Performance & Financial Health Analysis: Jenburkt vs Sequent Scientific

MetricJENBURPHSEQUENT
Market Information
Market Cap i₹4.87B₹48.13B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,9451,494,055
90 Day Avg. Volume i1,278754,164
Last Close₹1,074.90₹186.29
52 Week Range₹936.70 - ₹1,410.00₹117.35 - ₹240.70
% from 52W High-23.77%-22.60%
All-Time High₹1,410.00 (Jul 08, 2025)₹336.50 (Jun 28, 2021)
% from All-Time High-23.77%-44.64%
Growth Metrics
Quarterly Revenue Growth0.09%0.13%
Quarterly Earnings Growth0.05%1.20%
Financial Health
Profit Margin (TTM) i0.21%0.02%
Operating Margin (TTM) i0.23%0.08%
Return on Equity (TTM) i0.19%0.03%
Debt to Equity (MRQ) i2.2762.47
Cash & Liquidity
Book Value per Share (MRQ)₹389.23₹28.19
Cash per Share (MRQ)₹52.44₹2.52
Operating Cash Flow (TTM) i₹252.79M₹360.47M
Levered Free Cash Flow (TTM) i₹320.61M₹218.78M
Dividends
Last 12-Month Dividend Yield i2.48%N/A
Last 12-Month Dividend i₹33.30₹0.00

Valuation & Enterprise Metrics Analysis: Jenburkt vs Sequent Scientific

MetricJENBURPHSEQUENT
Price Ratios
P/E Ratio (TTM) i14.89166.33
Forward P/E i31.3836.89
PEG Ratio i2.911.40
Price to Sales (TTM) i3.123.00
Price to Book (MRQ) i2.816.61
Market Capitalization
Market Capitalization i₹4.87B₹48.13B
Enterprise Value i₹4.67B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i3.023.17
Enterprise to EBITDA i11.8830.63
Risk & Other Metrics
Beta i0.380.91
Book Value per Share (MRQ) i₹389.23₹28.19

Financial Statements Comparison: Jenburkt vs Sequent Scientific

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)JENBURPHSEQUENT
Revenue/Sales i₹355.27M₹4.41B
Cost of Goods Sold i₹65.18M₹2.35B
Gross Profit i₹290.09M₹2.07B
Research & Development iN/AN/A
Operating Income (EBIT) i₹82.35M₹333.50M
EBITDA i₹110.14M₹505.30M
Pre-Tax Income i₹101.82M₹255.20M
Income Tax i₹23.90M₹79.50M
Net Income (Profit) i₹77.92M₹175.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)JENBURPHSEQUENT
Cash & Equivalents i₹73.65M₹626.60M
Total Current Assets i₹565.32M₹8.74B
Total Current Liabilities i₹188.19M₹5.05B
Long-Term Debt i₹14.92M₹3.00B
Total Shareholders Equity i₹1.72B₹7.70B
Retained Earnings i₹1.62B₹1.25B
Property, Plant & Equipment i₹144.29M₹2.84B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)JENBURPHSEQUENT
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricJENBURPHSEQUENT
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,9451,494,055
Average Daily Volume (90 Day) i1,278754,164
Shares Outstanding i4.41M249.89M
Float Shares i1.77M118.88M
% Held by Insiders i0.73%0.52%
% Held by Institutions i0.00%0.13%

Dividend Analysis & Yield Comparison: Jenburkt vs Sequent Scientific

MetricJENBURPHSEQUENT
Last 12-Month Dividend i₹33.30₹0.00
Last 12-Month Dividend Yield i2.48%N/A
3-Year Avg Annual Dividend i₹19.90₹0.00
3-Year Avg Dividend Yield i1.83%N/A
3-Year Total Dividends i₹59.70₹0.00
Ex-Dividend DateJul 11, 2025N/A